Dr. David M. Milch
Chairman & Director
- 30+ years of global business experience in healthcare
- A founder, leader, and investor in life sciences, technology, and medical devices
- A visionary leader and investor in technology and life sciences including Heart Guard (start-up), American Blood Institute (private sale), Intelligent Medical Imaging (IPO), Biofield (IPO), Nitinol (IPO), Datatec Systems (reverse merger), Warp Technologies (reverse merger), MiniMed (acquired by Medtronic), Advanced Bionics (acquired by Boston Scientific), Theravance (IPO), Contrafect (IPO), Alpha Tau (private equity), Wisdo (private equity), Cyteir Therapeutics (private equity), Serpin Pharma (private equity), and Games 24x7 (private equity)
- Founder and Chairman of AllMed Solutions LTD, a public medical device technology company based in Israel